These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


544 related items for PubMed ID: 7741542

  • 1. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study.
    Kragballe K, Steijlen PM, Ibsen HH, van de Kerkhof PC, Esmann J, Sorensen LH, Axelsen MB.
    Arch Dermatol; 1995 May; 131(5):556-60. PubMed ID: 7741542
    [Abstract] [Full Text] [Related]

  • 2. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: a randomized controlled trial of supervised treatment of psoriasis vulgaris in a day-care setting.
    van de Kerkhof PC, van der Valk PG, Swinkels OQ, Kucharekova M, de Rie MA, de Vries HJ, Damstra R, Oranje AP, de Waard-van der Spek FB, van Neer P, Lijnen RL, Kunkeler AC, van Hees C, Haertlein NG, Hol CW.
    Br J Dermatol; 2006 Oct; 155(4):800-7. PubMed ID: 16965431
    [Abstract] [Full Text] [Related]

  • 3. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis.
    Zhu X, Wang B, Zhao G, Gu J, Chen Z, Briantais P, Andres P.
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):466-72. PubMed ID: 17373972
    [Abstract] [Full Text] [Related]

  • 4. Calcipotriol ointment versus cream in psoriasis vulgaris.
    Duweb G, Aldebani S, Elzorghany A, Benghazil M, Alhaddar J.
    Int J Clin Pharmacol Res; 2003 Apr; 23(2-3):47-51. PubMed ID: 15018018
    [Abstract] [Full Text] [Related]

  • 5. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903).
    Kragballe K.
    Arch Dermatol; 1989 Dec; 125(12):1647-52. PubMed ID: 2531570
    [Abstract] [Full Text] [Related]

  • 6. Calcipotriol-betamethasone ointment versus calcipotriol ointment in the treatment of psoriasis vulgaris.
    Duweb G, Alhaddar J, Elsherif B, Eljehawi N, Makhlouf H.
    Drugs Exp Clin Res; 2005 Dec; 31(5-6):175-9. PubMed ID: 16425973
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K, Noerrelund KL, Lui H, Ortonne JP, Wozel G, Uurasmaa T, Fleming C, Estebaranz JL, Hanssen LI, Persson LM.
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
    de Korte J, van der Valk PG, Sprangers MA, Damstra RJ, Kunkeler AC, Lijnen RL, Oranje AP, de Rie MA, de Waard-van der Spek FB, Hol CW, van de Kerkhof PC.
    Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
    [Abstract] [Full Text] [Related]

  • 10. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
    Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.
    J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
    [Abstract] [Full Text] [Related]

  • 11. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
    Lahfa M, Mrowietz U, Koenig M, Simon JC.
    Eur J Dermatol; 2003 Jul; 13(3):261-5. PubMed ID: 12804986
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group.
    Molin L, Cutler TP, Helander I, Nyfors B, Downes N.
    Br J Dermatol; 1997 Jan; 136(1):89-93. PubMed ID: 9039301
    [Abstract] [Full Text] [Related]

  • 13. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM.
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [Abstract] [Full Text] [Related]

  • 14. Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.
    Kragballe K, Fogh K, Søgaard H.
    Acta Derm Venereol; 1991 Apr; 71(6):475-8. PubMed ID: 1685828
    [Abstract] [Full Text] [Related]

  • 15. The use of topical calcipotriene/calcipotriol in conditions other than plaque-type psoriasis.
    Thiers BH.
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S69-71. PubMed ID: 9344189
    [Abstract] [Full Text] [Related]

  • 16. A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet/Daivobet/Taclonex) in the treatment of psoriasis vulgaris.
    Kragballe K, Austad J, Barnes L, Bibby A, de la Brassinne M, Cambazard F, Fleming C, Heikkilä H, Jolliffe D, Peyri J, Svensson A, Toole J, Wozel G.
    Br J Dermatol; 2006 Jun; 154(6):1155-60. PubMed ID: 16704648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A long-term multicentre assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis.
    Langner A, Ashton P, Van De Kerkhof PC, Verjans H.
    Br J Dermatol; 1996 Sep; 135(3):385-9. PubMed ID: 8949430
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 28.